Presented by Gilead Sciences Canada and ViiV Healthcare
Thursday, November 20
12:00–3:00 PM ET
Presenters: Darrell Tan, Tyrone Curtis, Ben Klassen, Caen Squires and others
In the nearly ten years since Health Canada’s approval of the first HIV PrEP option, community, clinical, and public health mobilization efforts have greatly expanded access to PrEP across 2S/GBTQ communities. However, inequities in access persist, especially among 2S/GBTQ communities who face intersecting barriers. New PrEP options, including long-acting injectables, may help address some of these underlying inequities by reducing challenges related to privacy and adherence. Additionally, newly updated clinical guidelines are making it easier to prescribe PrEP to a broader range of 2S/GBTQ people. Community-led priorities must continue to guide PrEP rollout to maximize the benefits for all 2S/GBTQ people in this new PrEP era. Join us as we share key clinical and research findings, discuss educational challenges and opportunities, and refine PrEP access priorities for our communities.
Click here to register.
Agenda:
12:00-12:30 PM ET
Lunch
12:30-1:20 PM ET
PrEP choice in the context of expanding options and new guidelines and what this means for diverse 2S/GBTQ folks
- 40 minute presentation adapted from CAHR
- 10 minute Q+A
1:20-1:35 PM
Sex Now PrEP presentation
- Highlighting findings related to awareness, interest, uptake and preferences for long-acting options
1:35-2:00 PM ET
Convening report back presentation
- Brief summary of goals, approach, who attended; share back key priorities that emerged for different stakeholders
- Outline key proposed outputs and solicit feedback
2:00-3:00 PM ET
Small group discussion and report back
